MindWalk Holdings Corp.

HYFT Healthcare Biotechnology

MindWalk Holdings Corp.’s revenue for fiscal 2026 (year ended April 2026) was $11.3 million, down 35.9% from fiscal 2025. In the quarter to July 2026, revenue grew 19.4%, EPS fell 80.0%, free cash flow grew 9.79% and total debt fell 10.8%, each against the same quarter a year earlier.

1.31 0.09 −6.43%
Market cap
$66.0M
P/E
0.0×
Fwd P/E
−9.0×
Dividend yield
—
F-score
6/9
Altman Z
−5.59
Beneish M
−3.70
Dividend safety
n/a
Older periods Oct '25 Jan '26 Apr '26 Jul '26
Piotroski F-Score

+8 more TTM periods

5 6 6 3
ROE
(116.44%) (63.81%) (79.38%) (122.85%)
ROA
(68.11%) (37.27%) (42.67%) (58.55%)
ROIC
(164.31%) (195.33%) (269.05%) (464.59%)
Return on Tangible Assets
(142.81%) (70.53%) (96.35%) (179.65%)
Average Days of Receivables
59.16 41.31 70.40 52.80
Free Cash Flow per Share
(0.16) (0.19) (0.20) (0.19)
Free Cash Flow
(7.31) (8.69) (9.32) (9.00)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Oct 2026